Focusfreda & CPHI China 2025 | Advancing Pharmaceutical Innovation with Medical-Grade Sodium Hyaluronate
Release time:
2025-06-19
Focusfreda is proud to join the global pharmaceutical community at CPHI China 2025, taking place from June 24–26 at the Shanghai New International Expo Centre (SNIEC). As part of the joint exhibition with the Freda Group, we invite you to visit our booth and discover our latest innovations in medical-grade Sodium Hyaluronate.
Leveraging our proprietary microbial fermentation platform and cutting-edge purification technologies, we offer a more full portfolio of pharma-grade Sodium Hyaluronate ingredients that meet more national standards. Our API grade Sodium Hyaluronate are registering in markets including China, South Korea, the EU, and India, with multiple DMF filings and custom formulation capabilities that support safety, efficacy, and compliance.
Whether you're a pharmaceutical manufacturer, R&D specialist, or regulatory expert, we welcome you to connect with our expert team and explore how our solutions can support your innovation pipeline.
Find us at E2B02 – CPHI China 2025, SNIEC, Shanghai
Let’s shape the future of Sodium Hyaluronate pharmaceutical science, together.
BLOGS
See You in Paris! Focusfreda Brings the "HA+" to in-cosmetics Global 2026
Join Focusfreda at in-cosmetics Global 2026 (Booth 2S59) in Paris. Discover our "HA+" philosophy and new biotech breakthroughs: Copper Lysinate Hyaluronate and Lysine Hyaluronate for sustainable, high-performance skincare.
Discover why the combination of Sodium Polyglutamate (Gamma-PGA) and Hyaluronic Acid (HA) is the new gold standard in professional skincare. Explore the science of the 3D Moisture Matrix and Focusfreda’s green bio-fermentation technology.
Explore the synergistic benefits of oral Sodium Hyaluronate and Ergothioneine (EGT). Learn how EGT stabilizes HA via the OCTN1 transporter to prevent oxidative degradation, enhancing bioavailability in next-generation longevity dietary supplements for 2026.
Good Breakthrough | FocusFreda Secures First NCI Registration for "Lysine Hyaluronate"
FocusFreda achieves a skincare milestone with the China NMPA registration of Lysine Hyaluronate (NCI No. 20260026). This innovative "Hyaluronic Acid+" ingredient combines essential amino acid for superior skin affinity, enzymatic stability, and synergistic repair. Explore how FocusFreda is leading the global shift toward high-end, science-backed green beauty solutions.
Knee osteoarthritis (KOA) is a common chronic joint disease with an increasing prevalence among older adults, severely impacting quality of life. Sodium hyaluronate (SH), as a core component of synovial fluid, is a key drug in KOA treatment. However, different molecular weights of SH exhibit significant differences in efficacy and mechanism of action, directly affecting treatment options. This article focuses on interpreting its differentiating effects to provide a reference for clinical application. [Reference Interpretation: Figure 1]
Is Hyaluronic Acid Ingredient Good for Acne? Safe Hydration for Breakout-Prone Skin
Learn whether hyaluronic acid is good for acne-prone skin, if it clogs pores, how it supports the skin barrier, and how to pair it with retinoids, niacinamide, and BHA—plus routine tips and FAQs.